Australia and New Zealand dialysis and transplant registry

Kidney International Supplements

Volumn 5, Issue 1, 2015, Pages 39-44

  McDonald, Stephen P ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

dialysis; end stage kidney disease; incidence; prevalence; registry

Indexed keywords

ALBUMINURIA; ARTICLE; AUSTRALIA AND NEW ZEALAND; CLINICAL RESEARCH; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FUNDING; GLOMERULONEPHRITIS; HEALTH CARE PLANNING; HEMODIALYSIS; HOME DIALYSIS; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; PATIENT SAFETY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; QUALITY CONTROL; REGISTER; RENAL REPLACEMENT THERAPY; TOTAL QUALITY MANAGEMENT;

EID: 84930149108     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2015.8     Document Type: Article

References (17)

1. Australian Commission on Safety and Quality in Health Care. Strategic and Operating Principles for a National Approach to Australian Clinical Quality Registries. ACSQHC: Sydney, 2010
2. Australian Commission on Safety and Quality in Health Care. Framework for Australian Clinical Quality Registries. ACSQHC: Sydney, 2014
3. Hoy WE, Mathews JD, McCredie DA et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296-1304
4. Australian Institute of Health and Welfare. Projections of the Prevalence of Treated End-Stage Kidney Disease in Australia 2012-2020. Cat. no. PHE 176. AIHW: Canberra, 2014
5. Jose MD, Johnson DW, Mudge DW et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology 2011; 16: 19-29
6. McDonald SP, Craig JC. Long term survival of children with end-stage renal disease. N Engl J Med 2004; 350: 2654-2662
7. Vajdic CM, McDonald SP, McCredie MRE et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831
8. McDonald SP, Marshall MR, Johnson DW et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155-163
9. Marshall MR, Byrne BG, Kerr PG et al. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 2006; 69: 1229-1236
10. Marshall MR, Hawley CM, Kerr PG et al. Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis 2011; 58: 782-793
11. Sparke C, Moon L, Green F et al. Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. Am J Kidney Dis 2013; 61: 413-419
12. Grace BS, Clayton P, Cass A et al. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrol Dial Transplant 2012; 27: 4173-4180
13. Grace BS, Clayton PA, Cass A et al. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int 2013; 83: 138-145
14. Grace BS, Clayton PA, Gray NA et al. Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol 2014; 9: 929-935
15. Jesudason S, Grace BS, McDonald SP. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 2014; 9: 143-149
16. Larsson S, Lawyer P, Garellick G et al. Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. Health Aff 2012; 31: 220-227
17. Lauer MS, D'Agostino RB. The randomized registry trial-the next disruptive technology in clinical research?. N Engl J Med 2013; 369: 1579-1581